Concepts (170)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tomography, X-Ray Computed | 24 | 2020 | 907 | 3.830 |
Why?
|
| Lung Neoplasms | 22 | 2021 | 423 | 3.230 |
Why?
|
| Lung Diseases | 4 | 2020 | 50 | 1.710 |
Why?
|
| Early Detection of Cancer | 9 | 2019 | 100 | 1.290 |
Why?
|
| Radiography, Thoracic | 5 | 2020 | 40 | 1.270 |
Why?
|
| Mass Screening | 9 | 2019 | 256 | 1.070 |
Why?
|
| Radiation Dosage | 6 | 2019 | 91 | 0.790 |
Why?
|
| Lung | 10 | 2020 | 263 | 0.780 |
Why?
|
| Incidental Findings | 3 | 2018 | 26 | 0.680 |
Why?
|
| Multiple Pulmonary Nodules | 2 | 2015 | 2 | 0.560 |
Why?
|
| Humans | 37 | 2021 | 32274 | 0.470 |
Why?
|
| Pleural Effusion | 1 | 2015 | 15 | 0.460 |
Why?
|
| Aorta, Thoracic | 1 | 2016 | 81 | 0.460 |
Why?
|
| Cone-Beam Computed Tomography | 1 | 2015 | 21 | 0.460 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 4 | 2021 | 116 | 0.440 |
Why?
|
| Smoking | 6 | 2021 | 505 | 0.420 |
Why?
|
| Coronary Artery Disease | 2 | 2015 | 427 | 0.420 |
Why?
|
| Carcinoma | 1 | 2015 | 92 | 0.420 |
Why?
|
| Middle Aged | 18 | 2021 | 11848 | 0.320 |
Why?
|
| Randomized Controlled Trials as Topic | 5 | 2019 | 541 | 0.300 |
Why?
|
| Aged | 15 | 2019 | 10260 | 0.270 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2019 | 108 | 0.240 |
Why?
|
| United States | 9 | 2021 | 4072 | 0.230 |
Why?
|
| National Cancer Institute (U.S.) | 2 | 2019 | 20 | 0.230 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2005 | 11 | 0.230 |
Why?
|
| Aneurysm, Dissecting | 1 | 2005 | 12 | 0.230 |
Why?
|
| Male | 17 | 2021 | 19437 | 0.220 |
Why?
|
| Female | 17 | 2021 | 19942 | 0.220 |
Why?
|
| Pulmonary Embolism | 1 | 2005 | 51 | 0.210 |
Why?
|
| Solitary Pulmonary Nodule | 2 | 2014 | 6 | 0.210 |
Why?
|
| Coronary Disease | 1 | 2005 | 226 | 0.200 |
Why?
|
| Heart Neoplasms | 1 | 2003 | 19 | 0.190 |
Why?
|
| Pericardium | 1 | 2003 | 52 | 0.190 |
Why?
|
| Thoracic Diseases | 1 | 2002 | 4 | 0.180 |
Why?
|
| Myocardium | 1 | 2003 | 184 | 0.180 |
Why?
|
| Sarcoidosis | 1 | 2002 | 33 | 0.180 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2005 | 1223 | 0.170 |
Why?
|
| Predictive Value of Tests | 4 | 2015 | 883 | 0.160 |
Why?
|
| Diagnosis, Differential | 3 | 2015 | 502 | 0.160 |
Why?
|
| Retrospective Studies | 4 | 2019 | 3624 | 0.160 |
Why?
|
| Nerve Tissue Proteins | 1 | 2021 | 124 | 0.160 |
Why?
|
| Receptors, Nicotinic | 1 | 2021 | 61 | 0.160 |
Why?
|
| Access to Information | 1 | 2020 | 13 | 0.160 |
Why?
|
| Sarcoidosis, Pulmonary | 2 | 2015 | 4 | 0.160 |
Why?
|
| Smoking Cessation | 2 | 2020 | 211 | 0.150 |
Why?
|
| Sarcopenia | 1 | 2019 | 50 | 0.140 |
Why?
|
| Telemedicine | 1 | 2020 | 122 | 0.140 |
Why?
|
| Biomedical Research | 1 | 2020 | 178 | 0.140 |
Why?
|
| Mediastinal Diseases | 1 | 2018 | 5 | 0.140 |
Why?
|
| Digestive System Diseases | 1 | 2018 | 5 | 0.140 |
Why?
|
| Thyroid Nodule | 1 | 2018 | 6 | 0.140 |
Why?
|
| Mediastinal Neoplasms | 1 | 2018 | 15 | 0.140 |
Why?
|
| Neoplasm Staging | 3 | 2019 | 461 | 0.140 |
Why?
|
| Medical Oncology | 1 | 2019 | 90 | 0.140 |
Why?
|
| Prevalence | 4 | 2019 | 955 | 0.140 |
Why?
|
| Neoplasms | 2 | 2020 | 754 | 0.130 |
Why?
|
| Interdisciplinary Communication | 1 | 2018 | 60 | 0.130 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2021 | 821 | 0.130 |
Why?
|
| False Positive Reactions | 2 | 2014 | 27 | 0.130 |
Why?
|
| Computer Communication Networks | 1 | 2016 | 4 | 0.120 |
Why?
|
| Body Surface Area | 1 | 2016 | 15 | 0.120 |
Why?
|
| Algorithms | 1 | 2019 | 536 | 0.120 |
Why?
|
| Reference Values | 1 | 2016 | 238 | 0.120 |
Why?
|
| Case-Control Studies | 2 | 2015 | 854 | 0.110 |
Why?
|
| Alveolitis, Extrinsic Allergic | 1 | 2015 | 1 | 0.110 |
Why?
|
| Pneumoconiosis | 1 | 2015 | 1 | 0.110 |
Why?
|
| Medical Illustration | 1 | 2015 | 5 | 0.110 |
Why?
|
| Bronchiolitis | 1 | 2015 | 3 | 0.110 |
Why?
|
| Cardiotonic Agents | 1 | 2015 | 41 | 0.110 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2015 | 13 | 0.110 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2015 | 24 | 0.110 |
Why?
|
| Coronary Circulation | 1 | 2015 | 41 | 0.110 |
Why?
|
| Echocardiography, Stress | 1 | 2015 | 23 | 0.110 |
Why?
|
| Myocardial Contraction | 1 | 2015 | 59 | 0.110 |
Why?
|
| Dobutamine | 1 | 2015 | 54 | 0.110 |
Why?
|
| Myocardial Ischemia | 1 | 2015 | 98 | 0.110 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2015 | 99 | 0.110 |
Why?
|
| Prediabetic State | 1 | 2015 | 76 | 0.100 |
Why?
|
| Academic Medical Centers | 1 | 2015 | 161 | 0.100 |
Why?
|
| Diagnostic Errors | 1 | 2014 | 38 | 0.100 |
Why?
|
| Incidence | 2 | 2021 | 1241 | 0.100 |
Why?
|
| Ventricular Function, Left | 1 | 2015 | 264 | 0.100 |
Why?
|
| Attitude of Health Personnel | 1 | 2015 | 183 | 0.100 |
Why?
|
| Cause of Death | 1 | 2013 | 236 | 0.090 |
Why?
|
| Risk Assessment | 2 | 2015 | 1425 | 0.090 |
Why?
|
| Practice Guidelines as Topic | 1 | 2015 | 395 | 0.090 |
Why?
|
| Emphysema | 1 | 2012 | 12 | 0.090 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2015 | 316 | 0.090 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 2011 | 7 | 0.090 |
Why?
|
| Central Venous Pressure | 1 | 2011 | 5 | 0.090 |
Why?
|
| Water-Electrolyte Balance | 1 | 2011 | 17 | 0.080 |
Why?
|
| Risk Factors | 5 | 2021 | 3934 | 0.080 |
Why?
|
| Fluid Therapy | 1 | 2011 | 25 | 0.080 |
Why?
|
| Acute Lung Injury | 1 | 2011 | 36 | 0.080 |
Why?
|
| Contusions | 1 | 2011 | 41 | 0.080 |
Why?
|
| Cost-Benefit Analysis | 1 | 2011 | 191 | 0.080 |
Why?
|
| Cardiovascular Diseases | 1 | 2018 | 1158 | 0.080 |
Why?
|
| Minority Groups | 1 | 2011 | 81 | 0.080 |
Why?
|
| Patient Selection | 1 | 2011 | 272 | 0.070 |
Why?
|
| Bronchi | 1 | 2009 | 33 | 0.070 |
Why?
|
| Contrast Media | 2 | 2015 | 136 | 0.070 |
Why?
|
| Foreign Bodies | 1 | 2009 | 28 | 0.070 |
Why?
|
| Trachea | 1 | 2009 | 53 | 0.070 |
Why?
|
| Ethnic Groups | 1 | 2011 | 450 | 0.070 |
Why?
|
| Accidents, Traffic | 1 | 2011 | 204 | 0.070 |
Why?
|
| Aged, 80 and over | 4 | 2018 | 3898 | 0.070 |
Why?
|
| Heart Failure | 1 | 2015 | 728 | 0.070 |
Why?
|
| Reproducibility of Results | 3 | 2015 | 757 | 0.060 |
Why?
|
| Age Factors | 3 | 2015 | 1179 | 0.060 |
Why?
|
| Radiographic Image Enhancement | 1 | 2005 | 30 | 0.060 |
Why?
|
| Hematoma | 1 | 2005 | 26 | 0.060 |
Why?
|
| Arteriosclerosis | 1 | 2005 | 147 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2005 | 232 | 0.050 |
Why?
|
| Pericardial Effusion | 1 | 2003 | 9 | 0.050 |
Why?
|
| Severity of Illness Index | 2 | 2017 | 853 | 0.050 |
Why?
|
| Lymphatic Diseases | 1 | 2002 | 11 | 0.040 |
Why?
|
| Neoplasm Metastasis | 1 | 2003 | 222 | 0.040 |
Why?
|
| Confidentiality | 1 | 2020 | 31 | 0.040 |
Why?
|
| RNA | 1 | 2021 | 94 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2017 | 2316 | 0.040 |
Why?
|
| Patient Participation | 1 | 2020 | 90 | 0.040 |
Why?
|
| Genotype | 1 | 2021 | 702 | 0.040 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 167 | 0.040 |
Why?
|
| Evidence-Based Medicine | 1 | 2019 | 212 | 0.040 |
Why?
|
| Mediastinum | 1 | 2018 | 14 | 0.030 |
Why?
|
| Thyroid Gland | 1 | 2018 | 16 | 0.030 |
Why?
|
| Esophagus | 1 | 2018 | 28 | 0.030 |
Why?
|
| Gastrointestinal Tract | 1 | 2018 | 40 | 0.030 |
Why?
|
| Decision Making | 1 | 2019 | 189 | 0.030 |
Why?
|
| Esophageal Neoplasms | 1 | 2018 | 39 | 0.030 |
Why?
|
| Program Development | 1 | 2018 | 93 | 0.030 |
Why?
|
| Lymph Nodes | 1 | 2018 | 113 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2018 | 171 | 0.030 |
Why?
|
| Spirometry | 1 | 2017 | 25 | 0.030 |
Why?
|
| Vital Capacity | 1 | 2017 | 37 | 0.030 |
Why?
|
| Forced Expiratory Volume | 1 | 2017 | 81 | 0.030 |
Why?
|
| Adult | 3 | 2015 | 9256 | 0.030 |
Why?
|
| Ventricular Remodeling | 1 | 2015 | 63 | 0.030 |
Why?
|
| Oxygen Consumption | 1 | 2015 | 141 | 0.030 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2014 | 83 | 0.030 |
Why?
|
| Radiography | 1 | 2015 | 362 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2015 | 471 | 0.030 |
Why?
|
| Probability | 1 | 2014 | 155 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 556 | 0.020 |
Why?
|
| Sex Factors | 1 | 2015 | 655 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2015 | 484 | 0.020 |
Why?
|
| Education | 1 | 2012 | 31 | 0.020 |
Why?
|
| Observer Variation | 1 | 2012 | 96 | 0.020 |
Why?
|
| Survival Rate | 1 | 2014 | 893 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2015 | 1840 | 0.020 |
Why?
|
| North Carolina | 1 | 2015 | 1300 | 0.020 |
Why?
|
| Costs and Cost Analysis | 1 | 2011 | 106 | 0.020 |
Why?
|
| Thoracic Injuries | 1 | 2011 | 52 | 0.020 |
Why?
|
| Lung Injury | 1 | 2011 | 67 | 0.020 |
Why?
|
| Research Design | 1 | 2012 | 314 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2011 | 388 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2011 | 368 | 0.020 |
Why?
|
| Airway Obstruction | 1 | 2009 | 29 | 0.020 |
Why?
|
| Respiratory Aspiration | 1 | 2009 | 24 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 2240 | 0.020 |
Why?
|
| Bronchoscopy | 1 | 2009 | 54 | 0.020 |
Why?
|
| Time Factors | 1 | 2014 | 2204 | 0.020 |
Why?
|
| Urogenital Neoplasms | 1 | 2005 | 5 | 0.010 |
Why?
|
| Thoracic Neoplasms | 1 | 2005 | 6 | 0.010 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2005 | 34 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2005 | 171 | 0.010 |
Why?
|
| Head and Neck Neoplasms | 1 | 2005 | 137 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2011 | 3416 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2005 | 393 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2005 | 762 | 0.010 |
Why?
|